Benzinga | Jul 12, 2021 07:28AM EDT

JP Morgan Downgrades Clover Health Investments to Underweight, Announces $9 Price Target

JP Morgan analyst Gary Taylor downgrades Clover Health Investments (NASDAQ:CLOV) from Neutral to Underweight and announces $9 price target.